These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6594011)

  • 1. Is fibrocystic breast disease a pre-malignant state?
    Myhre E
    Acta Obstet Gynecol Scand Suppl; 1984; 123():189-91. PubMed ID: 6594011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why the term 'low-grade ductal carcinoma in situ' should be changed to 'borderline breast disease': diagnostic and clinical implications.
    Masood S
    Womens Health (Lond); 2012 Jan; 8(1):57-62. PubMed ID: 22171775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-risk breast lesions].
    Bild E
    Rev Med Chir Soc Med Nat Iasi; 1998; 102(1-2):29-35. PubMed ID: 10756809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathology, systematic aspects and classification of benign breast diseases].
    Bässler R; Kind M
    Gynakologe; 1989 Aug; 22(4):216-25. PubMed ID: 2676756
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is fibrocystic disease precancerous?].
    De León Antoni E
    Bol Asoc Med P R; 1989 Nov; 81(11):451-4. PubMed ID: 2690835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign breast disease and the risk of breast cancer in the next 15 years.
    Socolov D; Anghelache I; Ilea C; Socolov R; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):135-40. PubMed ID: 25970956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is 'fibrocystic disease' of the breast precancerous? A consensus report from the College of American Pathologists.
    Indiana Med; 1986 Sep; 79(9):753-4. PubMed ID: 3772069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A; Shibi R; Kopolovitz G
    Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma.
    Goldstein NS; O'Malley BA
    Am J Clin Pathol; 1997 May; 107(5):561-6. PubMed ID: 9128269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrocystic breast disease--breast cancer sequence].
    Habor V; Habor A; Copotoiu C; Panţîru A
    Chirurgia (Bucur); 2010; 105(2):191-4. PubMed ID: 20540231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between benign breast proliferation (fibrocystic mastopathy) and the appearance of breast carcinoma].
    Alexa O; Stolnicu S; Horváth E; Jung J
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):101-9. PubMed ID: 12089936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphometric analysis of fibrocystic breast disease].
    Guski H; Freitag A; Hufnagl P; Voss K; Wenzelides K; Simon H
    Zentralbl Allg Pathol; 1986; 132(4):293-300. PubMed ID: 3026118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patho-epidemiology of benign proliferative epithelial disorders of the female breast.
    Cook MG; Rohan TE
    J Pathol; 1985 May; 146(1):1-15. PubMed ID: 3891937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The breast: tissue changes and cancer risk.
    Sinclair RA
    Med J Aust; 1988 Oct; 149(8):424-6. PubMed ID: 3173205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign and malignant proliferative epithelial lesions of the breast; a review.
    Azzopardi JG
    Eur J Cancer Clin Oncol; 1983 Dec; 19(12):1717-20. PubMed ID: 6319145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.